Fluoroquinolones in upper respiratory tract infections

BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6929.657c (Published 05 March 1994) Cite this as: BMJ 1994;308:657
  1. M Spiteri
  1. Department of Respiratory Medicine, City General Hospital, Stoke on Trent ST4 6QG.

    EDITOR, - Roland J Korner and colleagues' article on the dangers of oral fluoroquinolone in community acquired upper respiratory tract infections raises interesting questions.1 In the first case reported, a single dose of any antimicrobial drug would have been unlikely to affect the course of the patient's illness, pneumococcal meningitis. Interestingly, the patient's treatment in hospital consisted initially of cefotaxime and metronidazole; only after the results of culture were obtained was this changed to …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription